Kinins, the long march - A personal view

Cardiovascular Research

Volumn 54, Issue 3, 2002, Pages 485-491

  Erdös, Ervin G ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIDASE; AMINOPEPTIDASE; ANGIOTENSIN; ARACHIDONIC ACID; ARGININE CARBOXYPEPTIDASE; BETA 1 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; BRADYKININ; CAPTOPRIL; CARBOXYPEPTIDASE; CARBOXYPEPTIDASE C; CARBOXYPEPTIDASE M; CHOLINESTERASE; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; G PROTEIN COUPLED RECEPTOR; ICATIBANT; KALLIKREIN; KININ; MEMBRANE METALLOENDOPEPTIDASE; PREKALLIKREIN; PROLINE CARBOXYPEPTIDASE; UNCLASSIFIED DRUG;

CARBOXY TERMINAL SEQUENCE; DRUG EFFECT; EDITORIAL; ENZYME ACTIVATION; ENZYME INACTIVATION; ENZYME INHIBITION; ENZYME METABOLISM; ENZYME RELEASE; HUMAN; KALLIKREIN KININ SYSTEM; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; BRADYKININ; DIABETIC NEPHROPATHIES; HEART FAILURE, CONGESTIVE; HUMANS; HYPERTENSION; KALLIKREIN-KININ SYSTEM; KIDNEY; KININS; PEPTIDYL-DIPEPTIDASE A; RECEPTORS, BRADYKININ;

EID: 0036267811     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(02)00284-5     Document Type: Editorial

References (66)

1. Perspectives on the early history of angiotensin-converting enzyme - Recent follow-ups
2. Über eine neue blutdrucksenkende, darm und uteruserregende Substanz im menschlichen Urin
3. Potentiation of bradykinin actions by ACE inhibitors
4. Replacement of the transmembrane anchor in angiotensin I-converting enzyme (ACE) with a glycosylphosphatidylinositol tail affects activation of the B2 bradykinin receptor by ACE inhibitors
5. Bioregulation of kinins: Kallikreins, kininogens, and kininases
6. Bradykinin, kallidin and kallikrein
7. The kallikrein-kininogen-kinin system: Lessons from the quantification of endogenous kinins
8. The B1 receptors for kinins
9. Differential pharmacology of cloned human and mouse B2 bradykinin receptors
10. Cloning and pharmacological characterization of a rabbit bradykinin B1 receptor
11. Bradykinin Receptors
12. Angiotensin receptors: History and mysteries
13. The synthesis of bradykinin and of related peptides
14. Automated peptide synthesis
15. Hypotensive peptides, bradykinin, kallidin and eledoisin
16. Enzymatic studies on bradykinin and similar peptides
17. An enzyme in human blood plasma that inactivates bradykinin and kallidins
18. Inactivation and potentiation of the effects of bradykinin
19. The nature of the kallidins released from human plasma by kallikreins and other enzymes
20. Recovery and conversion of kinins in exsanguinated rat preparations
21. Anaphylatoxin inactivator of human plasma: Its isolation and characterization as a carboxypeptidase
22. Metabolism of bradykinin by peptidases in health and disease
23. Carboxypeptidase-type kininase of human kidney and urine
24. Purification of a human urinary carboxypeptidase (kininase) distinct from carboxypeptidase A, B, or N
25. Human carboxypeptidase M: Purification and characterization of a membrane-bound carboxypeptidase that cleaves peptide hormones
26. Molecular cloning and sequencing of the cDNA for human membrane-bound carboxypeptidase M: Comparison with carboxypeptidases A, B, H and N
27. Carboxypeptidase M in cultured Madin-Darby canine kidney (MDCK) cells. Evidence that carboxypeptidase M has a phosphatidylinositol glycan anchor
28. An enzyme in microsomal fraction of kidney that inactivates bradykinin
29. Second kininase in human blood plasma
30. Sequencing and cloning of human prolylcarboxypeptidase (angiotensinase C): Similarity to both serine carboxypeptidase and prolylendopeptidase families
31. New enzymatic route for the inactivation of angiotensin
32. Angiotensin-(1-7): A bioactive fragment of the renin-angiotensin system
33. The deduced protein sequence of the human carboxypeptidase N high molecular weight subunit reveals the presence of leucine-rich tandem repeats
34. A dipeptidyl carboxypeptidase that converts angiotensin I and inactivates bradykinin
35. Characterization of a dipeptide hydrolase (kininase II; Angiotensin I converting enzyme)
36. Biochemistry of angiotensin converting enzyme
37. Differences in the hydrolysis of enkephalin congeners by the two domains of angiotensin converting enzyme
38. An angiotensin converting enzyme inhibitor to identify and treat vasoconstrictor and volume factors in hypertensive patients
39. Angiotensin-converting enzyme (ACE) inhibitors in the prevention of cardiovascular disease: Clinical evidence
40. Inhibition of either angiotensin-converting enzyme (ACE) or angiotensin II activity: Effects on renal disease progression
41. Contribution of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors
42. Effects of ramipril on coronary events in high-risk persons: Results of the Heart Outcomes Prevention Evaluation Study
43. Neure Aspekte der Kininforschung. I. Potenzierung und Blockierung der biologischen Kininwirkung
44. Potentiation of the effects of bradykinin on its receptor in the isolated guinea pig ileum
45. SQ14,225 (D-3-mercapto-2-methylpropanoyl-L-proline), a novel orally active inhibitor of angiotensin I-converting enzyme
46. Angiotensin I-converting enzyme inhibitors potentiate bradykinin's inotropic effects independently of blocking its inactivation
47. Angiotensin-converting enzyme inhibitor ramiprilat interferes with the sequestration of the B2 kinin receptor within the plasma membrane of native endothelial cells
48. ACE inhibitors are endothelium dependent vasodilators of coronary arteries during submaximal stimulation with bradykinin
49. Local regulation of vascular tone by bradykinin and angiotensin converting enzyme inhibitors
50. ACE inhibitor potentiation of bradykinin-induced venoconstriction
51. Bradykinin potentiation by angiotensin-(1-7) and ACE inhibitors correlates with ACE C- and N-domain blockade
52. Molecular biology of the angiotensin I converting enzyme: II. Structure-function. Gene polymorphism and clinical implications
53. Neprilysin inhibitors potentiate effects of bradykinin on B2 receptor
54. 2 receptor
55. Human converting enzyme
56. Mouse angiotensin-converting enzyme is a protein composed of two homologous domains
57. Two putative active centers in human angiotensin I-converting enzyme revealed by molecular cloning
58. Single-domain angiotensin converting enzyme (kininase II): Characterization and properties
59. N-domain specific substrates and C-domain inhibitors of angiotensin converting enzyme: Angiotensin-(1-7) and keto-ACE
60. Peptidyl-dipeptidase A/angiotensin I-converting enzyme
61. Effects of the N-terminal sequence in the N-domain of ACE on the properties of its C-domain
62. Protein kinase C and phosphatase inhibitors block the ability of angiotensin I-converting enzyme inhibitors to resensitize the receptor to bradykinin without altering the primary effects of bradykinin
63. Kinins, receptors, kininases and inhibitors - Where did they lead us?
64. Bradykinin, kallidin and kallikrein
65. Human bradykinin B2 receptor is activated by kallikrein and other serine proteases
66. B1 bradykinin receptors and carboxypeptidase M are both upregulated in the aorta of pigs after LPS infusion